<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DD21B8FC-26A6-4A3A-9A23-207B6667CB41"><gtr:id>DD21B8FC-26A6-4A3A-9A23-207B6667CB41</gtr:id><gtr:name>University of Pittsburgh</gtr:name><gtr:address><gtr:line1>University of Pittsburgh</gtr:line1><gtr:line4>Pittsburgh</gtr:line4><gtr:line5>Pennsylvania</gtr:line5><gtr:postCode>PA 15260</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/956E999D-84FF-4CBE-8DDF-49169EA9E142"><gtr:id>956E999D-84FF-4CBE-8DDF-49169EA9E142</gtr:id><gtr:name>Carnegie Mellon University</gtr:name><gtr:address><gtr:line1>5000 Forbes Avenue</gtr:line1><gtr:line4>Pittsburgh</gtr:line4><gtr:line5>PA 15213</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DD21B8FC-26A6-4A3A-9A23-207B6667CB41"><gtr:id>DD21B8FC-26A6-4A3A-9A23-207B6667CB41</gtr:id><gtr:name>University of Pittsburgh</gtr:name><gtr:address><gtr:line1>University of Pittsburgh</gtr:line1><gtr:line4>Pittsburgh</gtr:line4><gtr:line5>Pennsylvania</gtr:line5><gtr:postCode>PA 15260</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/956E999D-84FF-4CBE-8DDF-49169EA9E142"><gtr:id>956E999D-84FF-4CBE-8DDF-49169EA9E142</gtr:id><gtr:name>Carnegie Mellon University</gtr:name><gtr:address><gtr:line1>5000 Forbes Avenue</gtr:line1><gtr:line4>Pittsburgh</gtr:line4><gtr:line5>PA 15213</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/12C54480-A4EB-44AC-997B-B44CF4F2F020"><gtr:id>12C54480-A4EB-44AC-997B-B44CF4F2F020</gtr:id><gtr:firstName>Michel</gtr:firstName><gtr:surname>Modo</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802552"><gtr:id>99E4F894-E186-4960-BA40-375701F5CA8C</gtr:id><gtr:title>Molecular and cellular imaging of transplanted cells in Huntington s disease.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0802552</gtr:grantReference><gtr:abstractText>Brain damage and neurodegeneration currently place an ever increasing burden on society. At present pharmacological approaches show only a limited success in the treatment of most neurological conditions. The use of stem cells (an immature type of cell with the potential to differentiate into all types of cells in a human body) for transplantation into the damaged brain hold immense potential to restore behaviour and reduced quality of life following neurodegeneration. However, no satisfactory objective method currently exists to directly monitor stem cell therapy. Therefore, monitoring of stem cell therapy is of utmost importance in our evaluation of the survival of these transplanted cells and to foster our understanding of how these cells actually promote recovery. Our laboratory has described a new, non-invasive method involving magnetic resonance imaging (MRI) to repeatedly follow the survival and migration of stem cells in the living brain. We propose to further develop and use such methods to study how stem cells integrate into the damaged brain and to examine if these transplants differentiate into the appropriate types of cells necessary to facilitate recontruction and recovery. The development of these methods is vital to promote a safe and rational application of stem cell therapy in a clinical setting.</gtr:abstractText><gtr:technicalSummary>The use of neural stem cells for transplantation to recover lost functions after brain damage is an exciting new treatment strategy that could benefit a wide variety of patients suffering from pathological conditions marked by cellular loss. Traditional snapshot, histological studies provide information pertaining to stem cell migration and integration at post-mortem only and such methods cannot capture the temporal dynamics of anatomical changes leading to behavioural recovery. However, to date, the in vivo monitoring of neural stem cell therapy has been difficult. The aim of our current research is to further develop previously described in vivo neuroimaging to guide, monitor and assess neural stem cell transplantation for Huntington s disease. Specifically, we propose to use a clinical-grade fluorine MRI contrast agent that is less likely to affect cellular functions than other labels and afford a selective detection of grafted cells that does not interfere with in vivo MRI assessments of pathology. It will hence be possible to assess how grafted human neural stem cells alter the progression of Huntington s like neurodegeneration in a rat model. The use of a clinical-grade fluorine agent and a human neural stem cell line here will provide evidence that this approach can be implemented to guide, monitor and assess clinical trials of stem cell therapy. Non-invasive imaging, as proposed here, will be key to ensure the safe and efficient translation of stem cell therapy from preclinical to clinical applications.</gtr:technicalSummary><gtr:fund><gtr:end>2011-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>268384</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pittsburgh</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Decellularised Matrices</gtr:description><gtr:id>BD2CC141-6931-4353-AD3F-1899A281F950</gtr:id><gtr:impact>Jin, T., Nicholls, F.J., Ghuman, H., Badylak, S.F., Modo, M. Diamagnetic chemical exchange saturation transfer (dia-CEST) affords magnetic resonance imaging of extracellular matrix hydrogel implantation in a rat model of stroke. Biomaterials. 2017; 113:176-190. PMID: 27816001.

Massensini, A., Ghuman, H., Medberry, C.J., Ling, W., Nicholls, F.J., Badylak, S.F., Modo, M. Concentration-dependent intracerebral delivery of ECM hydrogel to a stroke cavity. Acta Biomaterialia. 2015; 27:116-130. PMID: 26318805.</gtr:impact><gtr:outcomeId>gEe92gyE7yR-1</gtr:outcomeId><gtr:partnerContribution>Provide decellularised extracellular matrix for transplantation</gtr:partnerContribution><gtr:piContribution>We have integrated neural stem cells witihin decellularised extracellular matrices for transplantation and are evaluating its use to regrow lost brain tissue.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Carnegie Mellon University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Fluorinated MRI contrast agents</gtr:description><gtr:id>81077650-6230-498A-89F2-38B3F5217F38</gtr:id><gtr:impact>None so farBible, E., Dell'Acqua, F., Solanky, B., Bladucci, A., Crapo, P., Badylak, S.F., Ahrens, E.T., Modo, M. Non-invasive imaging of transplanted human neural stem cells and ECM scaffold remodelling in the stroke-damaged rat brain by 19F- and diffusion-MRI. Biomaterials. 2012; 33, 2858-2871. PMID: 22244696.</gtr:impact><gtr:outcomeId>RzVi2p3MRdh-1</gtr:outcomeId><gtr:partnerContribution>Provided bimodal fluorinated MRI contrast agent</gtr:partnerContribution><gtr:piContribution>We have established the in vitro effects of their agent on neural stem cells and evaluated its use for in vivo visualisation of transplanted cells.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Our project is investigating the use of 19F contrast agent. To be able to visualise this agent and its location within the brain, we needed to acquire a dual frequency coil. We commissioned this from David Herlihy (Imperial College) and have started to use this over the last 2 months.</gtr:description><gtr:id>8C0013FE-BEB2-4ECA-849B-68E03CC4F767</gtr:id><gtr:impact>More efficient use of scanning time and higher scientific accuracy.</gtr:impact><gtr:outcomeId>8DBF869EA45</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Radiofrequency coil that detects both 1H and 19F</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>53E0882F-4E84-43BC-A920-406AB0EA19AF</gtr:id><gtr:title>Non-invasive imaging of transplanted human neural stem cells and ECM scaffold remodeling in the stroke-damaged rat brain by (19)F- and diffusion-MRI.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/09122d203400bd3c3d986c3c607fd2c2"><gtr:id>09122d203400bd3c3d986c3c607fd2c2</gtr:id><gtr:otherNames>Bible E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn><gtr:outcomeId>pm_23794_24_22244696</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9FE112FE-DE04-4F38-BBE7-8D50B86DB2D3</gtr:id><gtr:title>Implantation site and lesion topology determine efficacy of a human neural stem cell line in a rat model of chronic stroke.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60a25835a2b5de16921804d374f9d906"><gtr:id>60a25835a2b5de16921804d374f9d906</gtr:id><gtr:otherNames>Smith EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_23794_24_22213183</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7111DB51-5A50-4F77-A047-C59242360089</gtr:id><gtr:title>Advances in the application of MRI to amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Expert opinion on medical diagnostics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea741f74cf7c60cbe6521035c8abbc4c"><gtr:id>ea741f74cf7c60cbe6521035c8abbc4c</gtr:id><gtr:otherNames>Turner MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1753-0059</gtr:issn><gtr:outcomeId>pm_540e167e1672ce7be</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A2E8A58-FA05-4621-9469-6EE8357479F2</gtr:id><gtr:title>Purmorphamine increases DARPP-32 differentiation in human striatal neural stem cells through the Hedgehog pathway.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/430ec4d954d273e09aa2c65dbfa2c4f2"><gtr:id>430ec4d954d273e09aa2c65dbfa2c4f2</gtr:id><gtr:otherNames>El-Akabawy G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn><gtr:outcomeId>J9AXyjNkVkZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5604BF13-3B95-4812-8C21-1F485898F5D7</gtr:id><gtr:title>Profiling metabolite changes in the neuronal differentiation of human striatal neural stem cells using 1H-magnetic resonance spectroscopy.</gtr:title><gtr:parentPublicationTitle>Neuroreport</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/126caef83b6c32da651122724b24b84a"><gtr:id>126caef83b6c32da651122724b24b84a</gtr:id><gtr:otherNames>Chung YL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-4965</gtr:issn><gtr:outcomeId>pm_540e167e1674f3a58</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E4456EFB-4281-4FFF-A013-BD7B709458CA</gtr:id><gtr:title>Tracking transplanted cells by MRI - methods and protocols.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07241bdfbdb969ebc1384dd5914bd8c6"><gtr:id>07241bdfbdb969ebc1384dd5914bd8c6</gtr:id><gtr:otherNames>Modo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>pm_540e167e16737b7f1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F47A7A47-E44E-462D-BCB2-526F200F2691</gtr:id><gtr:title>Use of magnetic resonance imaging contrast agents to detect transplanted liver cells.</gtr:title><gtr:parentPublicationTitle>Topics in magnetic resonance imaging : TMRI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0097962fad188c57a174162d8b307161"><gtr:id>0097962fad188c57a174162d8b307161</gtr:id><gtr:otherNames>Puppi J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0899-3459</gtr:issn><gtr:outcomeId>pm_540e167e167219d1d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5803EDA-A8AC-4879-BD4E-BE093A4403F7</gtr:id><gtr:title>MR diffusion histology and micro-tractography reveal mesoscale features of the human cerebellum.</gtr:title><gtr:parentPublicationTitle>Cerebellum (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21f7275789151c097ea6ddc9d799444f"><gtr:id>21f7275789151c097ea6ddc9d799444f</gtr:id><gtr:otherNames>Dell'Acqua F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1473-4222</gtr:issn><gtr:outcomeId>pm_540e167e1674355bf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6490E90D-8366-49B1-B53C-7C91404F2198</gtr:id><gtr:title>Implantation of undifferentiated and pre-differentiated human neural stem cells in the R6/2 transgenic mouse model of Huntington's disease.</gtr:title><gtr:parentPublicationTitle>BMC neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/430ec4d954d273e09aa2c65dbfa2c4f2"><gtr:id>430ec4d954d273e09aa2c65dbfa2c4f2</gtr:id><gtr:otherNames>El-Akabawy G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-2202</gtr:issn><gtr:outcomeId>pm_23794_24_22876937</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802552</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>12A0B409-0C29-4056-9092-2D86E44017F3</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.4  Methodologies and measurements</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>